Overview
The WHO Global Clinical Trials Forum (GCTF) network members will convene at WHO headquarters in Geneva to review progress across the network and strengthen collaboration in order to advance implementation of World Health Assembly resolution WHA75.8 on strengthening clinical trials.
Discussions will focus on how GCTF members can contribute to knowledge-sharing and capacity-building, local leadership and ecosystem strengthening, the contextualization of WHO norms and standards, and stakeholder engagement and advocacy. They will also consider how GCTF’s value, contribution and progress can be measured, reported and demonstrated through 2027.
Participants
The meeting will involve representatives of GCTF member organizations and invited contributors working to strengthen clinical trial ecosystems, including public health authorities, regulatory and ethics bodies, research institutions, funders, industry associations, patient and community organizations, and other partners.
Programme overview
- Opening remarks from the WHO Chief Scientist and the Science for Health Director.
- Reflections from GCTF members on Vasee’s legacy.
- Member success stories on implementing WHA75.8 and strengthening clinical trial ecosystems.
- Panel discussions on knowledge-sharing and capacity-building, local leadership, contextualizing WHO norms and standards, and stakeholder engagement and advocacy.
- Breakout discussions to define GCTF outcomes, measures of progress and contribution through 2027.
- Report-back from the breakout groups and co-design of practical mechanisms for coordination, communication, and collaboration.
Registration and participation
There is no public registration for the meeting. Participation in this meeting is by invitation and is limited to GCTF member organizations and invited contributors.
Key outcomes and follow-up information will be shared through GCTF communication channels after the meeting.